Cargando…

High PD-L1 expression is associated with a favorable prognosis in patients with esophageal squamous cell carcinoma undergoing postoperative adjuvant radiotherapy

Previous results on the prognostic value of programmed death-ligand (PD-L)1 expression in patients with esophageal squamous cell carcinoma (ESCC) remain limited and conflicting. The present study aimed to determine whether PD-L1 expression status predicts prognosis in patients with ESCC, particularl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Chenxue, Zhu, Yaoyao, Tang, Shuiqin, Zhang, Gu, Lin, Qingren, Xu, Yaping, Shang, Jinbiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341902/ https://www.ncbi.nlm.nih.gov/pubmed/30675222 http://dx.doi.org/10.3892/ol.2018.9747

Ejemplares similares

Radiosensitizing effect of c-Met kinase inhibitor BPI-9016M in esophageal squamous cell carcinoma cells in vitro and in vivo
por: Jiang, Chenxue, et al.
Publicado: (2021)

Association between IDO activity and prognosis in patients with non-small cell lung cancer after radiotherapy
por: Zhu, Yaoyao, et al.
Publicado: (2020)

Combination of Haemoglobin and Prognostic Nutritional Index Predicts the Prognosis of Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma
por: Wang, Bei, et al.
Publicado: (2020)

Delayed postoperative radiotherapy might improve the long-term prognosis of locally advanced esophageal squamous cell carcinoma
por: Lin, Ming-qiang, et al.
Publicado: (2020)

Effect of different surgical approaches on the prognosis of patients with postoperative radiotherapy for stage IIB–IVA esophageal squamous cancer
por: Gao, Mingcheng, et al.
Publicado: (2022)

Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer
por: Ito, Masaaki, et al.
Publicado: (2021)

Postoperative Adjuvant Therapy for Patients with pN+ Esophageal Squamous Cell Carcinoma
por: Li, Juan, et al.
Publicado: (2021)

Efficacy of postoperative adjuvant chemotherapy for esophageal squamous cell carcinoma: A meta‐analysis
por: Zhao, Peiliang, et al.
Publicado: (2018)

CD103(+) tumor-infiltrating lymphocytes predict favorable prognosis in patients with esophageal squamous cell carcinoma
por: Chu, Yifan, et al.
Publicado: (2019)

Relationship between postoperative nodal skip metastasis of mid-thoracic esophageal squamous cell carcinoma and patient prognosis and its value in guiding postoperative adjuvant treatment
por: Gao, Hong-Mei, et al.
Publicado: (2023)

Surgery and postoperative radiotherapy affect the prognosis of esophageal cancer: A SEER analysis
por: Yang, Wenwen, et al.
Publicado: (2023)

Immunoscore Signature Predicts Postoperative Survival and Adjuvant Chemotherapeutic Benefits in Esophageal Squamous Cell Carcinoma
por: Zhuge, Lingdun, et al.
Publicado: (2020)

The Prognosis and Feasibility of Extensive Clinical Target Volume in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial
por: Zhang, Xiaofei, et al.
Publicado: (2021)

Clinicopathological analysis of 67 cases of esophageal neuroendocrine carcinoma and the effect of postoperative adjuvant therapy on prognosis
por: Liu, Shenxiang, et al.
Publicado: (2021)

Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?
por: Xu, Yaping, et al.
Publicado: (2012)

Optimal Adjuvant Treatment for Curatively Resected Thoracic Esophageal Squamous Cell Carcinoma: A Radiotherapy Perspective
por: Kim, Kyung Hwan, et al.
Publicado: (2017)

Stereotactic body radiotherapy for early stage non-small cell lung cancer in patients with subclinical interstitial lung disease
por: Liu, Yuanjun, et al.
Publicado: (2020)

Adjuvant Therapy for Esophageal Squamous Cell Carcinoma
por: Sun, Jong-Mu
Publicado: (2020)

Postoperative Adjuvant Radiotherapy for Patients with Gastric Adenocarcinoma
por: Lim, Do Hoon
Publicado: (2012)

Sarcopenia is associated with prognosis in patients with esophageal squamous cell cancer after radiotherapy or chemoradiotherapy
por: Qian, Junchao, et al.
Publicado: (2022)

Clinicopathological characteristics and postoperative prognosis of patients with nuclear pedigree of esophageal squamous cell carcinoma
por: Wei, Meng Xia, et al.
Publicado: (2023)

PD-1 and PD-L1 co-expression predicts favorable prognosis in gastric cancer
por: Wu, Yanhua, et al.
Publicado: (2017)

Comparison and Prognostic Analysis of Adjuvant Radiotherapy versus Salvage Radiotherapy for Treatment of Radically Resected Locally Advanced Esophageal Squamous Cell Carcinoma
por: Xu, Xin, et al.
Publicado: (2016)

Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping
por: Jesinghaus, Moritz, et al.
Publicado: (2017)

Treatment results and prognostic factors of patients undergoing postoperative radiotherapy for laryngeal squamous cell carcinoma
por: Jin, Ting, et al.
Publicado: (2011)

Adjuvant Postoperative Radiotherapy with or without Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: The Importance of Patient Selection for the Postoperative Chemoradiotherapy
por: Lee, Jong Hoon, et al.
Publicado: (2013)

Tertiary lymphoid structures favor outcome in resected esophageal squamous cell carcinoma
por: Li, Rutao, et al.
Publicado: (2022)

Plasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinoma
por: Zhang, Danhong, et al.
Publicado: (2015)

PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups
por: Schmidt, Lars Henning, et al.
Publicado: (2015)

PD-L1 Expression On tumor Cells Was Associated With Unfavorable Prognosis In Esophageal Squamous Cell Carcinoma
por: Wang, Qiao, et al.
Publicado: (2018)

Postoperative radiotherapy for the young–old patients with thoracic esophageal squamous cell carcinoma: A 2-center experience
por: Ding, Wei, et al.
Publicado: (2020)

A retrospective study: the prevalence and prognostic value of anemia in patients undergoing radiotherapy for esophageal squamous cell carcinoma
por: Zhang, Fang, et al.
Publicado: (2014)

The development of a nomogram and the prognostic prediction value of patients with esophageal squamous cell carcinoma undergoing radical radiotherapy
por: Xiao, Ling, et al.
Publicado: (2022)

Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors
por: Liu, Rui-qing, et al.
Publicado: (2013)

Postoperative Radiotherapy of Prostate Cancer: Adjuvant versus Early Salvage
por: Wegener, Daniel, et al.
Publicado: (2022)

Advanced moderately differentiated neuroendocrine carcinoma of the rectum with favorable prognosis by postoperative chemoradiation
por: Nojima, Hiroyuki, et al.
Publicado: (2010)

The Role of Adjuvant Chemoradiotherapy Over Radiotherapy After R0 Resection for Stage II-III Esophageal Squamous Cell Carcinoma
por: Song, Tao, et al.
Publicado: (2020)

Chemokine-like factor-like MARVEL transmembrane domain-containing 3 expression is associated with a favorable prognosis in esophageal squamous cell carcinoma
por: Han, Tianci, et al.
Publicado: (2017)

Postoperative adjuvant chemotherapy versus chemoradiotherapy for node-positive esophageal squamous cell carcinoma: a propensity score-matched analysis
por: Wang, Qifeng, et al.
Publicado: (2020)

Association of survival with adjuvant radiotherapy for pN0 esophageal cancer
por: Gao, Huijiang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1fjfm16qj3q3s8ls5m1je5l2hl